BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 27, 2004
View Archived Issues
Enhancement of memory T-cells may improve vaccine therapies
Read More
New approvals for tamsulosin formulations
Read More
Promising results with small molecule MIF inhibitors in a preclinical model of colitis
Read More
Taiho patent covers new antiarthritic agents
Read More
Novel HDL-increasing agents developed at Eisai
Read More
Novel PDE4 inhibitors prepared and tested at Kyowa Hakko
Read More
Oxazepine-based antitumor agents newly discovered at Servier
Read More
Novel DPP-IV inhibitors and their use in type 2 diabetes claimed by Merck
Read More
New antitumor, antibacterial and antifungal agents isolated from Streptomyces sp.
Read More
Pfizer researchers describe new cannabinoid CB1 antagonists
Read More
Micrologix Biotech changes name to Migenix
Read More
Introgen Therapeutics receives NCI grant to further mda-7 gene research
Read More
Ceregene begins phase I trial of novel gene therapy for Alzheimer's disease
Read More
GSK grants Kenyan company license for manufacture and sale of HIV/AIDS medicines in Africa
Read More
Pharmion's MAA for Vidaza accepted for review by EMEA
Read More
Good safety profile reported for the NYVAC-HIVC vaccine in healthy volunteers
Read More
Phase II trial of Infecton for the detection of bacterial osteomyelitis initiated
Read More
Therapeutic benefits of SomatoKine in a child with Leprechaunism
Read More
E.U. approves Xenical label change
Read More
Clinical evidence for the efficacy of topiramate in the prevention of migraine
Read More
CytoVax and Millenium enter into definitive merger agreement
Read More
Phase I study for novel antibiotic WAP-8294A2 commences in U.S.
Read More
Fast track designation for Aurexis
Read More
FDA grants priority review to investigational female testosterone patch
Read More
Roche and Glycart to discover next-generation therapeutic antibodies
Read More
Enrollment completed for U.S. phase II Psoraxine study
Read More
GW-274150 reduces experimental neuropathic hypersensitivity
Read More
In vivo effects of capsaicin reduced by GW-833972
Read More
AF-3191 effective in preclinical pain models
Read More